Sign in
4/A

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-24-100745

Options or other derivatives

  • Chief Commercial Officer acquired 750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Wiley Matthew T. · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-15 Exercise or conversion : show line 1 in the form Restricted Stock Units −750 8,250 D
Loading xslF345X05/tm2424255-4_4aseq1.xml…